Serial #79384287
LIVE

Serial Number

79384287

Owner

CELLTRION, INC.

Filing Date

Sep 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79384287 Trademark

Serial Number: 79384287 • Registration: 7490889

Serial #79384287 is a trademark filed by CELLTRION, INC. on September 8, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELLTRION, INC. (115 trademarks)

23, Academy-ro,

Entity Type: 03

Trademark Details

Filing Date

September 8, 2023

Registration Date

September 3, 2024

Published for Opposition

June 18, 2024

Goods & Services

Pharmaceutical preparations for treating respiratory organs; allergy medications; immunizing agent, namely, pharmaceutical preparation for the treatment of immune system related diseases and disorders; immunosuppressant pharmaceutical preparations; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating chronic urticaria

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 17, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 29, 2025 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 4, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 3, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 28, 2024 GPNX
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 14, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 13, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 12, 2024 OP2R
NOTICE OF PUBLICATION
May 29, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2024 CNSA
ASSIGNED TO EXAMINER
May 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 22, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 13, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 30, 2023 REPR